NYSE$MPT
Medical Properties Trust Inc · Q4 2024 earnings
Q4 2024 earnings · · Before market open · Investor relations
Briefing
Medical Properties Trust reported a net loss and NFFO for Q4 2024. The company completed significant asset monetization transactions and addressed debt maturities through 2026.
Medical Properties Trust reported a net loss of ($0.69) per share and Normalized Funds from Operations (NFFO) of $0.18 per share for the fourth quarter of 2024. The results include impairments and fair market value adjustments related to Prospect Medical Group and PHP Holdings. The company completed a $2.5 billion senior secured notes offering and amended its line of credit, addressing debt maturities through 2026.
- Net loss of ($0.69) per share and NFFO of $0.18 per share for Q4 2024.
- Completed a $2.5 billion senior secured notes offering to repay debt maturities through October 2026.
- Amended line of credit to share collateral with the new senior secured notes.
- Commenced rent on a $50 million building improvement project in Idaho Falls, Idaho.
Headline financials
Revenue & EPS history
Medical Properties Trust · Revenue · Quarterly
$232M
Revenue by segment
Medical Properties Trust · $307M total across 4 segments · Q3 2023
- Rent Billed$229M-1.3%74.8%
- Interest and Other Income$29.7M-29.9%9.7%
- Income from Financing Leases$26.1M-48.9%8.5%
- Straight-line Rent$21.5M-19.0%7.0%
Forward guidance
Medical Properties Trust focused on addressing debt maturities through transaction proceeds. The company's real estate portfolio remains attractive to investors. Portfolio operator diversification improved, positioning MPT for shareholder value initiatives in 2025.
Tailwinds
- Proceeds from transactions used to accelerate repayment of debt maturities
- Global real estate portfolio remains attractive to sophisticated investors
- Improved the operator diversification of our portfolio
- Effectively addressed all debt maturities through 2026
- Positioning MPT to pursue a range of shareholder value initiatives in 2025
Headwinds
- Risk that the outcome and terms of the bankruptcy restructuring of Prospect will not be consistent with those anticipated by the Company
- Risk that previously announced or contemplated property sales, loan repayments, and other capital recycling transactions do not occur as anticipated or at all
- MPT’s ability to obtain or modify the terms of debt financing on attractive terms or at all, as a result of changes in interest rates and other factors, which may adversely impact its ability to pay down, refinance, restructure or extend its indebtedness as it becomes due, or pursue acquisition and development opportunities
- The ability of our tenants, operators and borrowers to satisfy their obligations under their respective contractual arrangements with us
- The ability of our tenants and operators to operate profitably and generate positive cash flow, remain solvent, comply with applicable laws, rules and regulations in the operation of our properties, to deliver high-quality services, to attract and retain qualified personnel and to attract patients
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
+1.3%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+0.7%
Avg return
30 days after
65%
42 / 65 earnings
Positive
+17.0%
Q4 2024
Best reaction
-15.8%
Q2 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.6% | -4.1% | -6.0% | |
| Q4 2025 | +12.1% | +6.1% | -15.1% | |
| Q3 2025 | +6.6% | +1.4% | +18.5% | |
| Q1 2025 | -6.9% | -8.0% | -17.2% | |
| Q4 2024 | +17.0% | +18.2% | +26.6% | |
| Q3 2024 | +7.0% | -5.2% | -9.8% | |
| Q2 2024 | +1.5% | +2.4% | +7.4% | |
| Q1 2024 | +7.2% | +31.2% | +20.4% | |
| Q4 2023 | +2.5% | +6.7% | +13.9% | |
| Q3 2023 | +9.9% | +7.2% | +4.7% | |
| Q2 2023 | -15.8% | -20.0% | -33.4% | |
| Q1 2023 | +10.6% | +4.9% | -0.1% | |
| Q4 2022 | -13.5% | -15.6% | -38.3% | |
| Q3 2022 | +6.8% | +6.5% | +20.6% | |
| Q2 2022 | -5.3% | -4.3% | -15.3% | |
| Q1 2022 | +4.1% | +6.3% | +5.2% | |
| Q4 2021 | -4.0% | -5.2% | -10.2% | |
| Q3 2021 | +0.1% | -1.2% | +1.5% | |
| Q2 2021 | +1.3% | -1.5% | -3.3% | |
| Q1 2021 | -2.0% | -4.1% | -5.9% | |
| Q4 2020 | +0.0% | +1.6% | -2.9% | |
| Q3 2020 | +3.7% | +10.9% | +13.8% | |
| Q2 2020 | -0.8% | -1.6% | -8.5% | |
| Q1 2020 | +4.1% | +0.5% | +9.8% | |
| Q4 2019 | +2.3% | +3.6% | +1.1% | |
| Q3 2019 | +1.2% | -6.8% | +0.9% | |
| Q2 2019 | +2.1% | -0.1% | +6.2% | |
| Q1 2019 | +3.8% | +1.2% | +2.0% | |
| Q4 2018 | +3.4% | +1.7% | +1.1% | |
| Q3 2018 | +3.2% | +9.9% | +16.2% | |
| Q2 2018 | +1.0% | +3.0% | +4.2% | |
| Q1 2018 | +1.8% | +2.0% | +5.6% | |
| Q4 2017 | +1.6% | +1.5% | +6.6% | |
| Q3 2017 | +3.2% | +3.9% | +4.8% | |
| Q2 2017 | -1.7% | +0.1% | +5.2% | |
| Q1 2017 | +2.1% | +2.5% | +4.3% | |
| Q4 2016 | +1.8% | +1.8% | -6.3% | |
| Q3 2016 | -0.8% | +1.3% | -2.7% | |
| Q2 2016 | +1.1% | +2.0% | -0.5% | |
| Q1 2016 | +3.8% | — | — | |
| Q4 2015 | -2.5% | — | — | |
| Q3 2015 | -3.4% | — | — | |
| Q2 2015 | -3.8% | — | — | |
| Q1 2015 | +2.9% | — | — | |
| Q4 2014 | +0.4% | — | — | |
| Q3 2014 | +2.7% | — | — | |
| Q2 2014 | -0.3% | — | — | |
| Q1 2014 | -0.9% | — | — | |
| Q4 2013 | -0.4% | — | — | |
| Q3 2013 | -0.7% | — | — | |
| Q2 2013 | -2.8% | — | — | |
| Q1 2013 | -1.0% | — | — | |
| Q4 2012 | +1.1% | — | — | |
| Q3 2012 | +3.1% | — | — | |
| Q2 2012 | +0.7% | — | — | |
| Q1 2012 | -0.1% | — | — | |
| Q4 2011 | -0.6% | — | — | |
| Q4 2009 | -0.6% | — | — | |
| Q3 2011 | -4.4% | — | — | |
| Q2 2011 | +4.5% | — | — | |
| Q1 2011 | +2.8% | — | — | |
| Q4 2010 | +2.8% | — | — | |
| Q3 2010 | +0.5% | — | — | |
| Q2 2010 | +1.0% | — | — | |
| Q1 2010 | +7.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro